Drug Development Program definition

Drug Development Program means the aggregate drug development activities related to each Development Candidate through completion of the first Phase 2 PoC Trial under a Collaboration Program in accordance with the applicable Initial Development Plan for all Collaboration Programs under this Agreement.
Drug Development Program means a drug development program conducted by LeukoSite, its Affiliates or sublicensees, at no cost to the Company, for pre-clinical and clinical development, regulatory approval, and commercialization of a Product Candidate that was included in a CytoMed Program.
Drug Development Program means that program conducted by BMS at its cost and in the exercise of its sole and absolute discretion pertaining to the pre-clinical and clinical development, regulatory filings, and commercialization of a Lead Compound.

Examples of Drug Development Program in a sentence

  • WYETH-AYERST agrees that it will exert commercially reasonable drug development and marketing efforts that are consistent with those efforts undertaken in its own global pharmaceutical business to develop and market in the Field, throughout such areas of the Territory as it may reasonably determine, at its own expense, Antibacterial Products incorporating or derived from any Compounds which receive Antibacterial Product Designation (a "Drug Development Program").

  • Research Program shall refer only to the collaborative phase of the research effort and shall not refer to the selection of a Safety Assessment Candidate by Merck or to the Drug Development Program.

  • WYETH-AYERST will keep SIGA fully informed concerning the status of the Drug Development Program for each Licensed Product, it being understood that all such information is Confidential Information subject to all the terms and conditions of this Agreement, and particularly Article 4 hereof.

  • WYETH-AYERST will keep CHEMGENICS fully informed concerning the status of the Drug Development Program for each Antibacterial Product, it being understood that all such information is Confidential Information subject to all the terms and conditions of this Agreement, and particularly Article 5 hereof.

  • The progress and results of Merck's Drug Development Program, as well as such other information reasonably requested by Transcell relating to the progress, goals or performance of the Drug Development Program, will be reported to Transcell through semi-annual summary reports.

  • The Global Development Plan shall describe the activities to be carried out by Wyeth during each year of the Drug Development Program.

  • WYETH-AYERST or its Affiliates shall conduct a drug development program to develop Licensed Products in the field of human medicine, and in its sole discretion and through an Affiliate, in veterinary medicine, and henceforth market Licensed Products in the Field incorporated or derived from any Compounds discovered or identified as a result of the R & D Program, which reach Pre- Project Status and which are selected by WYETH-AYERST or its Affiliates for development (a "Drug Development Program").

  • Continues Strong Performance from Consumer Products Division with Reported Sales of $2.5 Million for Q2 2016-Company Initiates Preclinical Drug Development Program to Address $5.3 Billion Market Opportunity in Cessation of Smokeless Tobacco Las Vegas, Nevada, August 12, 2016 – CV Sciences, Inc.

  • The National Cancer Institute Division of Cancer Prevention has established a Cancer Preclinical Drug Development Program called PREVENT.

  • Under the Drug Development Program, ATL will develop and commercialize antisense drugs arising out of the Collaborative Research Program conducted hereunder as well as ISIS 107248, a Collaboration Compound discovered by ISIS.


More Definitions of Drug Development Program

Drug Development Program means the drug development program to be carried out by Merck in accordance with Section 2.12.
Drug Development Program means the aggregate drug development activities related to each Development Candidate through [***] under a Collaboration Program in accordance with the applicable Development Plan for all Collaboration Programs under this Agreement.
Drug Development Program shall include any LEAD CANDIDATE DRUG DEVELOPMENT PROGRAM conducted under Paragraph 4 of this AMENDMENT NO. 2.

Related to Drug Development Program

  • Development Program means the implementation of the development plan.

  • Commercial Development Plan means the written commercialization plan attached as Appendix E.

  • Initial Development Plan has the meaning set forth in Section 3.2(b).

  • site development plan means a dimensioned plan drawn to scale that indicates details of the proposed land development, including the site layout, positioning of buildings and structures, property access, building designs and landscaping;

  • Development Plan has the meaning set forth in Section 3.2.

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • Global Development Plan has the meaning set forth in Section 3.1.

  • Development Plans has the meaning set forth in Section 3.2.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Marketing program means a program established by order of the director pursuant to this act prescribing rules and regulations governing the marketing for processing, distributing, selling, or handling an agricultural commodity produced in this state or agricultural commodity input during a specified period and

  • Development Activities means those activities which are normally undertaken for the development, construction, repair, renovation, rehabilitation or conversion of buildings for residential purposes, including the acquisition of property;

  • Development Phase means the period before a vehicle type is type approved.

  • spatial development framework means the Kouga Municipal Spatial Development Framework prepared and adopted in terms of sections 20 and 21 of the Act and Chapter 2 of this By-Law;

  • Development Team means the entities and professionals assembled to develop and manage the Project, typically including the Applicant, Owner, Developer(s), Co-Developer(s) and general partner or any other related entities in which the Developer or Co-Developer has an identity of interest or a Controlling Interest.

  • Infill development means new construction on a vacant commercial lot currently held as open space.

  • Development Activity means any activity defined as Development which will necessitate a Floodplain Development Permit. This includes buildings, structures, and non-structural items, including (but not limited to) fill, bulkheads, piers, pools, docks, landings, ramps, and erosion control/stabilization measures.

  • municipal spatial development framework means a municipal spatial development framework adopted by the Municipality in terms of Chapter 5 of the Municipal Systems Act;

  • Medical Affairs Activities means, with respect to any country or other jurisdiction in the Territory, the coordination of medical information requests and field based medical scientific liaisons with respect to Licensed Compounds or Licensed Products, including activities of medical scientific liaisons and the provision of medical information services with respect to a Licensed Compound or Licensed Product.

  • Development Works means the external development works and internal development works on immovable property;

  • Commercial Development means any development on private land that is not heavy industrial or residential. The category includes, but is not limited to: hospitals, laboratories and other medical facilities, educational institutions, recreational facilities, plant nurseries, car wash facilities, mini-malls and other business complexes, shopping malls, hotels, office buildings, public warehouses and other light industrial complexes.

  • Research and development facility means an establishment engaged in laboratory, scientific, or experimental testing and development related to new products, new uses for existing products, or improving existing products. The term does not include an establishment engaged in efficiency surveys, management studies, consumer surveys, economic surveys, advertising, promotion, banking, or research in connection with literary, historical, or similar projects.

  • Redevelopment Plan means the “Lincoln Center Redevelopment Plan” passed, adopted and approved by the City pursuant to the Resolution, and shall include any amendment of said Redevelopment Plan heretofore or hereafter made by the City pursuant to law.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Research and development means (1) theoretical analysis, exploration, or experimentation; or (2) the extension of investigative findings and theories of a scientific or technical nature into practical application for experimental and demonstration purposes, including the experimental production and testing of models, devices, equipment, materials, and processes. Research and development does not include the internal or external administration of radiation or radioactive material to human beings.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • scientific research means any activity in the field of natural or applied science for the extension of knowledge;